Click the “Start Activity” button to indicate you have reviewed the CME information for this activity.
Faculty
Parameswaran N. Hari, MD, MRCP, MS
Professor of Hematology
Director, Adult Blood and Marrow Transplant Program
Medical College of Wisconsin
Milwaukee, WI
Luciano J. Costa, MD, PhD
Associate Professor of Medicine
Blood and Marrow Transplantation and Cell Therapy Program
University of Alabama at Birmingham
Birmingham, AL
Release date: June 5, 2017
Expiration date: June 5, 2018
Program Overview
The goal of this educational program is to enhance the efficacy and safety of stem cell mobilization for donors of patients with multiple myeloma (MM) by spreading information of the most current and effective methods to physicians. Collecting stem cells for transplantation is necessary for many patients, as transplantation persists as an effective strategy for myeloma. New collection methods are arising and improving stem cell mobilization, and physicians should be kept up to date on the new options and guidelines for protecting donor safety.
Learning Objectives
The following are the learning objectives in CME format for this program. Upon completion of this program, participants will be able to:
• Identify existing and emerging strategies for optimizing stem cell mobilization
• Select optimal CD34 goals and strategies to achieve the best results
• Identify barriers to autologous transplants in MM
Target Audience
This activity has been developed and is intended for transplant specialists, oncologists, hematologists, and other healthcare professionals involved in the treatment of patients with hematologic malignancies.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Medical College of Wisconsin and Carden Jennings Publishing Co., Ltd. The Medical College of Wisconsin is accredited with commendation by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Medical College of Wisconsin designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
This enduring material is approved for one year from the date of original release, June 5, 2017 to June 5, 2018.
Off-Label/Investigational Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Medical College of Wisconsin, or Carden Jennings Publishing.
Before prescribing any medication, physicians should consult primary references and full prescribing information. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically, and are encouraged to consult appropriate resources for any product or device mentioned in this activity.
CJP Medical Communications Disclosure
The employees of CJP Medical Communications have no financial relationships to disclose.
Faculty Disclosures
Consistent with the current Accreditation Council for Continuing Medical Education policy, the CME Provider must be able to show that everyone who is in a position to control the content of an individual educational activity has disclosed all relevant financial relationships. The CME Provider has a mechanism in place to identify and resolve any conflicts of interest discovered in the disclosure process. The presenting faculty members have all made the proper disclosures, and the following relationships are relevant:
Parameswaran N. Hari, MD, MRCP, MS, discloses that he has received honoraria and served as a consultant for Sanofi, Celgene, and Takeda.
Luciano Costa, MD, discloses that he has received honoraria and research funding from Sanofi and from Amgen, and has received honoraria from Celgene. He has served also as a consultant for Sanofi.
John R. Wingard, MD, has no relevant financial relationships to disclose.
Hemant Murthy, MD, has no relevant financial relationships to disclose.
Jack W. Hsu, MD, has no relevant financial relationships to disclose.
Click the “Start Activity” button to indicate you have reviewed the CME information for this activity.